Fabrice Anizon
Impact in
- Toxicology top 0.5%
- Bioactive Compounds and Antitumor Agents
- Organic Chemistry top 1%
- Synthesis and biological activity
- Synthesis and Biological Evaluation
- Catalytic C–H Functionalization Methods
- Quinazolinone synthesis and applications
Papers in
-
- Cancer therapeutics and mechanisms 39
- Phytochemical compounds biological activities 10
- DNA Repair Mechanisms 9
-
- Synthesis and biological activity 20
- Synthesis and Biological Evaluation 15
- Quinazolinone synthesis and applications 12
- Co-authors
- Pascale Moreau (71 shared papers)Michelle Prudhomme (40 shared papers)Bruno Pfeiffer (18 shared papers)F Giraud (30 shared papers)Eric Débiton (7 shared papers)Christian Bailly (11 shared papers)Lionel Nauton (18 shared papers)Vincent Théry (17 shared papers)
In The Last Decade
Fabrice Anizon
91 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 86
- Toxicology 352
- Organic Chemistry 1.3k
- Pathology and Forensic Medicine 349
- Molecular Biology 1.1k
- Pharmacology 200
Countries citing papers authored by Fabrice Anizon
This map shows the geographic impact of Fabrice Anizon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fabrice Anizon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fabrice Anizon more than expected).
Fields of papers citing papers by Fabrice Anizon
This network shows the impact of papers produced by Fabrice Anizon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fabrice Anizon. The network helps show where Fabrice Anizon may publish in the future.
Co-authors
The 25 scholars most cited alongside Fabrice Anizon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 95 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 98 | |
| 2 | 1997 | 87 | |
| 3 | 2009 | 85 | |
| 4 | 2009 | 69 | |
| 5 | 2007 | 63 | |
| 6 | 2010 | 59 | |
| 7 | 1998 | 56 | |
| 8 | 2005 | 55 | |
| 9 | 2015 | 55 | |
| 10 | 1999 | 54 | |
| 11 | 2007 | 54 | |
| 12 | 2005 | 49 | |
| 13 | 2007 | 45 | |
| 14 | 1999 | 45 | |
| 15 | 2010 | 41 | |
| 16 | 2004 | 41 | |
| 17 | 2016 | 35 | |
| 18 | 2007 | 34 | |
| 19 | 2012 | 33 | |
| 20 | 2007 | 32 |
About Fabrice Anizon
Fabrice Anizon is a scholar working on Molecular Biology, Organic Chemistry, Pathology and Forensic Medicine, Toxicology and Oncology, having authored 95 papers that have together received 2.1k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (39 papers), Bioactive Compounds and Antitumor Agents (24 papers), Cancer Mechanisms and Therapy (24 papers), Synthesis and biological activity (20 papers), Synthesis and Biological Evaluation (15 papers), Quinazolinone synthesis and applications (12 papers), Phytochemical compounds biological activities (10 papers) and DNA Repair Mechanisms (9 papers). The work is most often cited by research in Toxicology (352 citations), Organic Chemistry (1.3k citations), Pathology and Forensic Medicine (349 citations), Molecular Biology (1.1k citations) and Pharmacology (200 citations). Fabrice Anizon has collaborated with scholars based in France, Russia and Norway. Frequent co-authors include Pascale Moreau, Michelle Prudhomme, Bruno Pfeiffer, F Giraud, Eric Débiton, Christian Bailly, Lionel Nauton, Vincent Théry, Samir Messaoudi and Stéphane Léonce. Their work appears in journals such as European Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry, Journal of Medicinal Chemistry, Tetrahedron and Tetrahedron Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.